EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications

Mahewish Sayyad, Ashish Dilip Sutar, Kamini Shivhare, Rahul Shukla, Swaran J S Flora

Frontiers in Pharmacology · 27.11.2025 · 16

DOI: 10.3389/fphar.2025.1711653 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 27.11.2025. Verfasst von Mahewish Sayyad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Priyadarshini College of Engineering, Nagpur, India. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Silymarin, extracted from the seeds of Silybum marianum (milk thistle), has been utilised in traditional medicine for many years and is recognised for its neuroprotective and hepatoprotective properties. Existing research reveals that silymarin has potent antioxidant and anti-inflammatory effects, coupled with anti-fibrotic, anti-carcinogenic, neuro-regenerative, and immunomodulatory actions, and has broad therapeutic relevance in both neurological and hepatic disorders, albeit with the drawback of low solubility. Silymarin participates in multiple molecular and cellular pathways to show its therapeutic effect. Nanocarriers are a promising solution to silymarin’s low solubility and limited bioavailability, aiming to enhance targeted delivery to the central nervous system and hepatic tissue. These developments position silymarin as a multi-domain phytopharmaceutical with significant translational potential. This review provides an overview of silymarin’s historical context, phytochemical composition, and pharmacokinetic profile, with a particular focus on targeted drug delivery systems. Special emphasis is placed on its potential role in managing various diseases.

Schlagwörter

Stichwörter der Autor:innen

cellular pathwayherbal moietyimmunomodulatornanocarrierneuro-regenerative medicinesilymarin

Autor:innen und Institutionen

  • Department of Biotechnology, Priyadarshini College of Engineering, Nagpur, India.
  • Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER, Raebareli), Raebareli, India.
  • Department of Pharmacy, Era Medical College and University, Lucknow, India.

Zitieren

APA

Sayyad, M., Sutar, A. D., Shivhare, K., Shukla, R., & Flora, S. J. S. (2025). Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1711653

Vancouver

Sayyad M, Sutar AD, Shivhare K, Shukla R, Flora SJS. Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1711653

BibTeX
@article{Sayyad2025,
  author = {Sayyad, Mahewish and Sutar, Ashish Dilip and Shivhare, Kamini and Shukla, Rahul and Flora, Swaran J S},
  title = {Silymarin as a phytopharmaceutical agent: advances in mechanistic insights, formulation strategies, and pre-clinical applications},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1711653}
}
Kostenlos starten →